Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenues:
Product sales		$ 240
Total revenues		240
Cost of revenues:
Product sales		96
Total cost of revenues		96
Gross margin		144
Operating expenses:
Research and development expenses	34,129	84,189
Selling, general and administrative expenses	127,162	73,998
Total operating expenses	161,291	158,187
Operating loss	(161,291)	(158,043)
Other income (expense):
Gain on debt conversion		15,220
Change in fair value of derivatives	4,217	(23,631)
Interest expense	(29,483)	(69,660)
Net loss	(186,557)	(236,114)
Preferred stock dividend	(8,098)	(6,558)
Net loss applicable to common shareholders	$ (194,655)	$ (242,672)
Basic and diluted net loss per average share available to common shareholders (in Dollars per share)	$ 0.00	$ 0.00
Weighted average common shares outstanding – basic and diluted (in Shares)	73,554,897	72,802,438